LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

• Autores principales: Isabel Graupera (Autor), Maja Thiele (Autor), Ann T. Ma (Autor), Miquel Serra-Burriel (Autor), Judit Pich (Autor), Núria Fabrellas (Autor), Llorenç Caballeria (Autor), Robert J. de Knegt (Autor), Ivica Grgurevic (Autor), Mathias Reichert (Autor), Dominique Roulot (Autor), Jörn M. Schattenberg (Autor), Juan M. Pericas (Autor), Paolo Angeli (Autor), Emmanuel A. Tsochatzis (Autor), Indra Neil Guha (Autor), Montserrat Garcia-Retortillo (Autor), Rosa M. Morillas (Autor), Rosario Hernández (Autor), Jordi Hoyo (Autor), Matilde Fuentes (Autor), Anita Madir (Autor), Adrià Juanola (Autor), Anna Soria (Autor), Marta Juan (Autor), Marta Carol (Autor), Alba Diaz (Autor), Sönke Detlefsen (Autor), Pere Toran (Autor), Guillem Pera (Autor), Céline Fournier (Autor), Anne Llorca (Autor), Phillip N. Newsome (Autor), Michael Manns (Autor), Harry J. de Koning (Autor), Feliu Serra-Burriel (Autor), Fernando Cucchietti (Autor), Anita Arslanow (Autor), Marko Korenjak (Autor), Laurens van Kleef (Autor), Josep Lluis Falcó (Autor), Patrick S. Kamath (Autor), Tom H. Karlsen (Autor), Laurent Castera (Autor), Frank Lammert (Autor), Aleksander Krag (Autor), Pere Ginès (Autor), for the LiverScreen Consortium investigators (Autor)
• Formato: Libro
• Publicado: BMC, 2022-07-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Abstract Background The development of liver cirrhosis is usually an asymptomatic process until late stages when complications occur. The potential reversibility of the disease is dependent on early diagnosis of liver fibrosis and timely targeted treatment. Recently, the use of non-invasive tools ha...